ETV4 and cancer: Increased expression of TOP2A has been previously associated with poor cancer-specific survival in MPNSTs [11], whereas increased expression of ETV4, a member of the Ets family of transcription factors, has been associated with shorter patient survival in colorectal cancer [31] and gastric cancer [32].